Paladin Labs, a subsidiary of Endo International, Introduces XCOPRI (cenobamate tablets) in Canada as an Adjunctive Therapy for Partial-Onset Seizures in Adults.
Endo s Paladin Labs Launches XCOPRI in Canada, Providing New Treatment Option for Adults with Partial-Onset SeizuresMONTREAL, Jan. 22, 2024 - Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), made...
Jan 22, 2024
• Major Pharmaceutical Preparations Industry
Products & Services
OTC
